| Product NDC: | 45802-717 |
| Proprietary Name: | Terconazole |
| Non Proprietary Name: | Terconazole |
| Active Ingredient(s): | 80 mg/1 & nbsp; Terconazole |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | SUPPOSITORY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 45802-717 |
| Labeler Name: | Perrigo New York Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077149 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060828 |
| Package NDC: | 45802-717-08 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (45802-717-08) > 3 SUPPOSITORY in 1 BLISTER PACK |
| NDC Code | 45802-717-08 |
| Proprietary Name | Terconazole |
| Package Description | 1 BLISTER PACK in 1 CARTON (45802-717-08) > 3 SUPPOSITORY in 1 BLISTER PACK |
| Product NDC | 45802-717 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Terconazole |
| Dosage Form Name | SUPPOSITORY |
| Route Name | VAGINAL |
| Start Marketing Date | 20060828 |
| Marketing Category Name | ANDA |
| Labeler Name | Perrigo New York Inc |
| Substance Name | TERCONAZOLE |
| Strength Number | 80 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |